Safety and Immunogenicity of SARS-CoV-2 Protein Subunit Recombinant Vaccine
Clinical trial NCT05067894 · COMPLETED
Trial details
- NCT number
- NCT05067894
- Sponsor
- PT Bio Farma
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-10
- Primary completion
- 2022-04-11
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.